- Home
- MANE vs AGL Comparison
MANE vs AGL Comparison
Compare MANE & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MANE | AGL |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MANE | AGL |
|---|---|---|
| Price | $91.82 | $110.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 12 |
| Target Price | ★ $83.33 | $55.68 |
| AVG Volume (30 Days) | ★ 409.9K | 234.6K |
| Earning Date | 03-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.94 |
| Revenue | N/A | ★ $5,932,576,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | ★ N/A | $37.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.26 | $0.30 |
| 52 Week High | $117.71 | $118.25 |
Technical Indicators
Market Signals| Indicator | MANE | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 69.41 |
| Support Level | $92.94 | $0.62 |
| Resistance Level | $107.95 | N/A |
| Average True Range (ATR) | 6.50 | 9.73 |
| MACD | -1.04 | -0.59 |
| Stochastic Oscillator | 38.75 | 88.37 |
Price Performance
Historical ComparisonAbout MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
About AGL agilon health inc.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.